1-6 of 6
Kaitlyn O'Shea
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Frontline Treatment with Single Agent Pembrolizumab (PEM) Followed By AVD Chemotherapy for Classic Hodgkin Lymphoma: Updated Results and Correlative Analysis

Pamela Allen, Qing C Chen, Xinyan Lu, Kaitlyn O'Shea, Joan Chmiel, Madina Sukhanova, Liron Barnea Slonim, Hatice Savas, Eric Mou, Barbara Pro, Andrew M. Evens, Brett Alan Palmer, Ranjana Advani, Leo I. Gordon, Jane N. Winter
Journal: Blood
Blood (2021) 138 (Supplement 1): 231.
https://doi.org/10.1182/blood-2021-147042
Published: 2021
Journal Articles

Pembrolizumab (PEM) Added to ICE Chemotherapy Results in High Complete Metabolic Response Rates in Relapsed/Refractory Classic Hodgkin Lymphoma (cHL): A Multi-Institutional Phase II Trial

Locke J. Bryan, Carla Casulo, Pamela Allen, Scott E. Smith, Hatice Savas, Reem Karmali, Barbara Pro, Kaitlyn O'Shea, Joan Chmiel, Brett Alan Palmer, Jayesh Mehta, Leo I. Gordon, Jane N. Winter
Journal: Blood
Blood (2021) 138 (Supplement 1): 229.
https://doi.org/10.1182/blood-2021-145111
Published: 2021
Journal Articles

Outcomes and Treatment Patterns in Patients with Aggressive B-Cell Lymphoma after Failure of Anti-CD19 CAR T-Cell Therapy

Joanna C. Zurko, Narendranath Epperla, Imran Nizamuddin, Pallawi Torka, Kevin A. David, Thomas A. Ollila, Brian T. Hess, Jonathon B. Cohen, Robert Ferdman, Jieqi Liu, Sayan Mullick Chowdhury, Kaitlyn O'Shea, Jason Romancik, Rahul Bhansali, Elyse Harris, Mckenzie Sorrell, Rebecca Masel, Lindsey Fitzgerald, Carlos Galvez, Shuo Ma, Jane N. Winter, Barbara Pro, Leo I. Gordon, Alexey V. Danilov, Deborah M. Stephens, Nirav N. Shah, Geoffrey Shouse, Vaishalee P. Kenkre, Stefan K. Barta, Reem Karmali
Journal: Blood
Blood (2021) 138 (Supplement 1): 884.
https://doi.org/10.1182/blood-2021-147433
Published: 2021
Journal Articles

Practice Patterns Pre-CART for Aggressive B-Cell Lymphomas: Patient Selection and Real World Salvage and Bridging Practices

Imran Nizamuddin, Kevin A. David, Jonathon B. Cohen, Vaishalee P. Kenkre, Geoffrey Shouse, Brian T. Hess, Thomas A. Ollila, Deborah M. Stephens, Sayan Mullick Chowdhury, Robert Ferdman, Kaitlyn O'Shea, Jieqi Liu, Jason T. Romancik, Joanna C. Zurko, Rahul S. Bhansali, Elyse I. Harris, McKenzie Sorrell, Rebecca Masel, Lindsey Fitzgerald, Carlos Galvez, Shuo Ma, Jane N. Winter, Barbara Pro, Leo I. Gordon, Alexey V. Danilov, Nirav N. Shah, Stefan K. Barta, Narendranath Epperla, Pallawi Torka, Reem Karmali
Journal: Blood
Blood (2021) 138 (Supplement 1): 532.
https://doi.org/10.1182/blood-2021-147033
Published: 2021
Journal Articles

Pembrolizumab followed by AVD in untreated early unfavorable and advanced-stage classical Hodgkin lymphoma

Clinical Trials & Observations
Pamela B. Allen, Hatice Savas, Andrew M. Evens, Ranjana H. Advani, Brett Palmer, Barbara Pro, Reem Karmali, Eric Mou, Jeffrey Bearden, Gary Dillehay, Robert A. Bayer, Robert M. Eisner, Joan S. Chmiel, Kaitlyn O’Shea, Leo I. Gordon, Jane N. Winter
Journal: Blood
Blood (2021) 137 (10): 1318–1326.
https://doi.org/10.1182/blood.2020007400
Published: 2021
Includes: Supplemental data
Journal Articles

PD-L1 Pathway Markers and Chromosome 9p24.1 Alterations in Patients with Classic Hodgkin Lymphoma Treated with Frontline Single Agent Pembrolizumab (PEM) Followed By AVD Chemotherapy

Pamela B. Allen, MD MSc, Xinyan Lu, MD, Qing C Chen, MD PhD, Liron Barnea Slonim, MD, Madina Sukhanova, PhD, Hatice Savas, MD, Joan Chmiel, Kaitlyn O'Shea, Andrew M. Evens, DO,MMSc, Ranjana Advani, MD, Barbara Pro, MD, Reem Karmali, MDMSc, Brett Alan Palmer, BS, Jeffrey Bearden, BA, Eric Mou, MD, Gary Dillehay, MD, Leo I. Gordon, MD, Jane N. Winter, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 17–18.
https://doi.org/10.1182/blood-2020-139816
Published: 2020